MAPT and Alzheimer disease: The reliability of assessing 24-OHC in blood when investigating AD is further questioned by the fact that no strong correlation was found between plasma 24-OHC and traditional AD biomarkers (i.e., Aβ, t-tau and p-tau) [81].